The Boldt scandal still in need of action: the example of colloids 10 years after initial suspicion of fraud
- PMID: 29968012
- PMCID: PMC7572333
- DOI: 10.1007/s00134-018-5289-3
The Boldt scandal still in need of action: the example of colloids 10 years after initial suspicion of fraud
Erratum in
-
Correction to: The Boldt scandal still in need of action: the example of colloids 10 years after initial suspicion of fraud.Intensive Care Med. 2021 Feb;47(2):264. doi: 10.1007/s00134-020-06270-5. Intensive Care Med. 2021. PMID: 33048196 Free PMC article. No abstract available.
Conflict of interest statement
CJW has received lecture fees and/or travel cost reimbursements from the Plasma Protein Therapeutics Association, Kedrion, CSL Behring, Grifols and Baxter, and remuneration for consulting from CSL Behring, Grifols, and Daiichi Sankyo. MJ has received fees for lectures and/or consulting from Baxter, CSL Behring, Fresenius and Astute Medical, and research grand support from Fresenius.
Figures
References
-
- Klinikum Ludwigshafen (2010) Untersuchungsbericht der Kommission für die Pressekonferenz am 29. November 2010. https://www.klilu.de/content/veranstaltungen___presse/pressearchiv/2010/.... Accessed 9 Jun 2018
-
- Rasmussen LS, Yentis SM, Van Aken H et al (2011) Editors-in-chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt. Minerva Anesthesiol 77:562–563 - PubMed
-
- Boldt J, Brosch C, Ducke M, et al. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med. 2007;35:2740–2746. doi: 10.1097/01.CCM.0000288101.02556.DE. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
